Tin tức & Cập nhật
Xem bài viết Hô hấp
Xem
Chỉ hiển thị Multimedia

Fluvoxamine wins, metformin disappoints in long COVID fatigue
19 Jun 2026
bởiElvira Manzano
The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.
Fluvoxamine wins, metformin disappoints in long COVID fatigue
19 Jun 2026
Reduced RT plus chemo-immunotherapy feasible in older/frail NSCLC patients
18 Jun 2026
bởiStephen Padilla
In older or frail patients with stage III non-small cell lung cancer (NSCLC), undergoing reduced radiotherapy (RT) followed by sequential chemo-immunotherapy results in survival outcomes similar to standard RT, indicating its utility in vulnerable populations, suggests a study.







